In the News
Can Fido catch the fountain of youth?
The Dog Aging Project run by the Kaeberlein Lab covered by HealthDay
The Dog Aging Project is looking at a drug known as rapamycin, which is already approved by the U.S. Food and Drug Administration for use in people with cancer or who've had organ transplants.
One known action of the drug is to suppress the immune system, according to the U.S. National Cancer Institute. But paradoxically, a study by drug maker Novartis also found rapamycin appeared to boost the immune function of folks aged 65 and older....
What about humans? Right now, Matt Kaeberlein, leader of the Dog Aging Project, told HealthDay, "It's complete speculation, but with something like rapamycin, we might get 10 to 15, maybe as much as 20 years. And in most people, they would be healthy additional years."